Kristal Nessa
Medical · Las Vegas, NVNPI 1508802075
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,120 and has fallen 97.4% since, to $29 in 2024.
Across 122 payments — averaging $17.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$366
- Johnson & Johnson$226
- GSK$206
- Novo Nordisk$200
- AstraZeneca$182
- Abbott$177
- plus $779 from 20 others
What the payments were for
- Food & beverage$2,135100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $366 |
| Johnson & Johnson | 15 | $226 |
| GSK | 14 | $206 |
| Novo Nordisk | 11 | $200 |
| AstraZeneca | 5 | $182 |
| Abbott | 3 | $177 |
| Astellas Pharma US Inc | 10 | $157 |
| Amgen | 6 | $97 |
| Boehringer Ingelheim | 5 | $81 |
| Merck | 4 | $58 |
| Medtronic | 1 | $49 |
| Lilly USA, LLC | 2 | $34 |
| Amarin Pharma, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Nabriva Therapeutics, PLC | 2 | $28 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Pfizer | 1 | $19 |
| Bayer | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $19 |
| Novartis | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre 2$157
- BREZTRI$125
How this compares
$2,135 in reported general payments places this provider in the 65th percentile of 250 medical providers in Nevada.
Other medical in Las Vegas
- John NotabartoloLas Vegas$284K
- Rachel BowersLas Vegas$29K
- Spencer MeierLas Vegas$24K
- Megan WieselLas Vegas$19K
- Tai PhamLas Vegas$16K
- Eric HilmesLas Vegas$15K
- Wardon OjedapoLas Vegas$12K
- Melchor GochiocoLas Vegas$11K
- Keesha KaplanLas Vegas$11K
- Adelbert WadsworthLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.